Cybin: Top Value Psychedelic Stock (NYSE:CYBN)
The psychedelic medicine sector provides some unique value investment opportunities. Here’s why Cybin could be the best value bet among this group of biotech pioneers.
Senior editor and writer for major media and tech organizations. Expert in the emerging psychedelic medicine industry. Contributor to Seeking Alpha, National Geographic, Lonely Planet, and others.
As a former business owner and magazine founder, I understand the realities of producing content in a commercial world.
jnajum@gmail.com